Stroke remains a leading cause of death globally, with increased risk linked to lifestyle factors

The Lancet Neurology study provides updated estimates on stroke burden and risks, emphasizing the need for targeted interventions in high-risk regions.

Anti-Bias Tools Might Be Helping Boost Diversity in Ophthalmology Programs

Several bias reduction tools used by ophthalmology residency selection committees appeared to boost diversity in the programs, whereas others didn’t help or even hurt diversity,

April 2, 2024

Health startups need consolidation after pandemic funding ‘sugar high’

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. LAS VEGAS — Health startups will likely

October 24, 2024

Novartis pays $15M upfront to license Voyager program; Boehringer advances geographic atrophy drug

Plus, news about Jnana Therapeutics, Vaxcyte, C-Further, Genprex, PharmaEssentia, FORUS Therapeutics, Pharma Two B and Hepion: Novartis licenses Voyager program: Voyager will get $15 million

September 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.